Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Novo Holdings, a leading life science investor, today announced that it has invested in a $200M Series A launch financing for Windward ...

Boobalan Pachaiyappan, an analyst from Roth MKM, has initiated a new Buy rating on Verona Pharma (VRNA).Stay Ahead of the Market:Discover ...

The winter storm has brought heavy snow and ice to the region, impacting operations at Rick Husband Amarillo International ...

Combined airway valve therapy in severe emphysema improves lung function and walking distance for patients with heterogeneous disease, despite some risks.

The study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.

Sanofi’s Dupixent and new drugs drive growth, despite near-term pressures. See why SFY stock’s product pipeline makes it a ...

India is currently facing an unprecedented rise in Non-Communicable Diseases (NCDs) accounting for over 66 per cent of all ...

A virus causing cold-like symptoms is making its seasonal rounds, and health officials are urging everyone to take preventive ...

Scotland has the highest rate of drugs deaths in Europe, with fatalities rising by 12% in a year to 1,172 drug-related deaths ...

Windward Bio has landed with a flurry of announcements, circling in a $200 million series A and offering up to $970 million ...